VistaGen Therapeutics, Inc. logo VTGN - VistaGen Therapeutics, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 3
HOLD 4
SELL 0
STRONG
SELL
0
| PRICE TARGET: $0.95 DETAILS
HIGH: $1.00
LOW: $0.90
MEDIAN: $0.95
CONSENSUS: $0.95
UPSIDE: 64.87%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
Revenue
Revenue 0.5 1.1 (0.2) 1.1 1.1 0 0 0 1.2 0 0 0 0.2 1.3 0 0 0 0
Cost of Revenue 0 0 0 0 0 0.1 0.1 0.1 0 0.1 0 0 0 0 0 0 0 0
Gross Profit 0.5 1.1 (0.2) 1.1 1.1 (0.1) 0 0 1.2 0 0 0 0.2 1.3 0 0 0 0
Operating Expenses
R&D Expenses 39.4 20.0 44.4 35.4 11.9 13.3 17.1 7.8 5.2 3.9 2.4 2.5 3.4 5.4 0 0 0 0
SG&A Expenses 17.1 14.1 14.7 13.2 7.1 6.5 7.4 6.4 5.9 13.9 4.2 2.5 3.6 4.4 0.0 0.0 0.0 0.0
Other Expenses 0 0 0 0.2 (0.0) 0 (0.0) 0 0.4 (0.0) 0 0 0 0.6 0.0 0.0 0.0 0
Operating Expenses 56.5 34.1 59.0 48.9 19.0 19.9 24.5 14.2 11.5 17.9 6.7 5.0 7.0 10.4 0.0 0.0 0.0 0.0
Operating Income
Operating Income (56.0) (33.0) (59.3) (47.8) (17.9) (20.0) (24.6) (14.2) (10.2) (17.9) (6.8) (5.0) (6.8) (9.0) (0.0) (0.0) (0.0) (0.0)
Interest Expense 0 0 0.0 0 0.0 0.0 0.0 0.0 0.0 0.8 4.6 1.6 1.0 1.9 0 0 0 0
Interest Income 4.6 3.4 0.0 0.0 0.0 0.0 0 0 0 0 0.0 0.0 0.0 0.0 0 0 0 0
Profitability
EBITDA (50.8) (28.8) (58.7) (47.0) (17.4) (20.7) (24.5) (14.3) (9.8) (17.8) (6.7) (5.0) (11.8) (10.3) (6.3) (0.0) (0.0) (0.0)
EBIT (51.4) (29.4) (59.3) (47.8) (17.9) (20.8) (24.6) (14.3) (9.8) (17.9) (6.8) (5.0) (11.9) (10.3) (6.4) (0.0) (0.0) (0.0)
Income Before Tax (51.4) (29.4) (59.2) (47.8) (17.9) (20.8) (24.6) (14.3) (10.3) (47.2) (13.9) (3.0) (12.9) (12.2) (0.0) (0.0) (0.0) (0.0)
Income Tax Expense 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Net Income (51.4) (29.4) (59.2) (47.8) (17.9) (20.8) (24.6) (14.3) (10.3) (47.2) (13.9) (3.0) (12.9) (12.2) (0.0) (0.0) (0.0) (0.0)
Per Share Data
EPS (Basic) -1.67 -1.52 -8.51 -7.38 -14.74 -14.21 -25.83 -30.98 -40.85 -801.28 -318.27 -74.47 -426.99 -497.11 -0.46 -1.13 -0.95 -0.28
EPS (Diluted) -1.67 -1.52 -8.51 -7.38 -14.74 -14.21 -25.83 -30.98 -40.85 -801.27 -315.87 -81.00 -426.98 -497.11 -0.46 -1.13 -0.95 -0.28
Shares Outstanding 30.7 19.4 7.0 6.6 2.9 1.5 1.0 0.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
Current Assets
Cash & Cash Equivalents 67.1 119.2 16.6 68.1 103.1 1.4 13.1 10.4 2.9 0.4 0.1 (0.0) 0.6 0.1 0.0 0.0 0.0 0
Short-Term Investments 13.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Receivables 0 0 0.8 2.7 0.0 0 0.3 0 0 0 0 0.0 0 0.1 0 0 0 0
Inventory 0 0 0 0 0 0 0.2 0 0 0 0 0.0 0 0 0 0 0 0
Other Current Assets 1.6 0 0.1 (2.2) 0.2 0.1 0.2 0.6 0 0.4 0 0.0 0 0 0 0 0 0
Total Current Assets 82.1 120.7 17.5 71.0 104.1 1.6 13.7 11.0 3.4 0.9 0.1 0.0 0.7 0.2 0.0 0.0 0.0 0
Non-Current Assets
Property, Plant & Equipment 1.8 2.3 2.8 3.1 3.6 3.8 0.3 0.2 0.3 0.1 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 0.5 0.7 0.8 0.6 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0 0 0
Total Non-Current Assets 2.3 3.0 3.6 3.6 4.2 4.2 0.4 0.3 0.3 0.1 0.2 0.2 0.2 0.1 0.0 0.0 0.0 0
Total Assets 84.3 123.7 21.1 74.6 108.3 5.8 14.0 11.3 3.7 1.0 0.3 0.3 0.9 0.3 0.0 0.0 0.0 0
Current Liabilities
Account Payables 0.7 1.5 2.5 2.8 0.8 1.8 1.1 1.2 0.9 0.9 2.3 2.4 1.4 1.8 0.0 0.0 0.0 0.0
Short-Term Debt 0 0 0.1 0 0 0.1 0.1 0.1 0.1 0.0 13.9 2.1 0.7 0.8 0.0 0.0 0.0 0
Deferred Revenue 2.6 0 0.7 1.2 1.4 0 0 0 0 0 0 0 0 0.0 0 0 0 0
Other Current Liabilities 3.4 0.8 0.3 0.1 0 0 0 0 0 0 0 0.0 0.2 0.2 0 0 0 0
Total Current Liabilities 12.6 5.1 4.6 5.8 4.2 2.8 2.8 1.5 1.4 1.8 17.4 5.2 2.4 3.2 0.0 0.0 0.0 0.0
Non-Current Liabilities
Long-Term Debt 0 0 0 0 0 0 0 0 0 0.0 0.3 4.8 4.6 2.7 0 0 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 (0.1) 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 2.7 0 0 6.3 5.0 4.1 2.9 1.7 2.1 3.1 3.1 6.4 0.1 0 0 0 0
Total Non-Current Liabilities 1.3 4.2 4.4 4.2 12.1 8.7 4.1 2.9 1.7 2.2 3.4 7.9 11.0 2.9 0.0 0.0 0.0 0
Total Liabilities 14.0 9.4 9.0 9.9 16.3 11.5 6.9 4.4 3.1 4.0 20.8 13.1 13.4 6.0 0.0 0.0 0.0 0.0
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0
Retained Earnings (407.6) (356.2) (326.9) (267.6) (219.8) (201.9) (181.1) (156.5) (142.0) (131.7) (84.5) (70,636.9) (67,669,200) (54.8) (0.1) (0.0) (0.0) (0.0)
Accumulated Other Comprehensive Income 0.0 0 0 0 0 0 (0.0) (0.0) (0.0) (0.0) (0.0) (70.6) (67.7) (0.0) 0 (0.0) (0.0) 0
Total Stockholders' Equity 70.4 114.3 12.1 64.7 92.0 (5.7) 7.1 6.9 0.6 (3.0) (20.5) (12.8) (12.6) (5.7) (0.0) (0.0) 0.0 0
Total Liabilities & Equity 84.3 123.7 21.1 74.6 108.3 5.8 14.0 11.3 3.7 1.0 0.3 0.3 0.9 0.3 0.0 0.0 0.0 0
Debt Metrics
Total Debt 1.5 2.1 2.7 3.0 3.7 4.1 0.1 0.1 0.1 0.1 14.3 6.9 5.3 3.5 0.0 0.0 0.0 0
Net Debt (65.6) (117.0) (13.9) (65.1) (99.4) 2.7 (13.0) (10.3) (2.9) (0.4) 14.2 6.9 4.7 3.4 (0.0) 0 (0.0) 0
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009
Operating Activities
Net Income (51.4) (29.4) (59.2) (47.8) (17.9) (20.8) (24.6) (14.3) (10.3) (47.2) (13.9) (3.0) (12.9) (12.2) (0.0) (0.0) (0.0)
Depreciation & Amortization 0.6 0.6 0.5 0.7 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0
Stock-Based Compensation 4.3 2.2 3.3 3.5 2.3 3.8 3.4 2.3 0.9 4.0 2.5 1.1 1.2 1.6 0 0 0
Change in Working Capital 4.8 0.8 2.0 (1.9) 3.1 0.2 1.7 0.7 (0.7) (0.5) 2.1 2.3 1.5 2.7 0.0 (0.0) 0.0
Other Non-Cash Items (0.4) 0.0 3.6 0.2 0 0.9 4.7 1.8 2.0 2.8 4.0 0.7 1.0 1.7 0 0 0
Operating Cash Flow (42.1) (25.8) (49.7) (45.3) (12.1) (15.8) (14.5) (9.1) (7.3) (4.8) (2.8) (2.1) (3.5) (3.6) (0.0) (0.0) (0.0)
Investing Activities
Capital Expenditure (0.2) (0.1) (0.2) (0.2) (0.3) 0 (0.2) (0.0) (0.2) (0.0) 0 (0.0) (0.1) (0.0) 0 0 (0.0)
Acquisitions 0 0 (0.5) 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Purchases of Investments (25.0) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sales/Maturities of Investments 12.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Investing Activities 0 0 0 0 0 0 (174) (1.6) (239.1) 0 0 (9.6) 0 (32,400) 0 0 0
Investing Cash Flow (13.1) (0.1) (0.7) (0.2) (0.3) 0 (0.2) (0.0) (0.2) (0.0) 0 (0.0) (0.1) (0.0) 0 0 (0.0)
Financing Activities
Net Debt Issuance 0 (1.0) (1.0) (0.0) (0.4) (0.3) (0.0) (0.0) (0.0) (0.1) (0.3) (0.2) 2.7 (0.3) 0.0 0 0.0
Stock Repurchased 0 0 (0.2) 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 (945.1) 0 0 (1,139.9) (1,030.4) (1,257) 0 0 0 0 0 0 0 0
Other Financing Activities 0.2 0.0 0.1 951.1 5.0 0.7 1,157.3 1,046.9 1,267.0 5.3 0 1.7 0.3 1.2 0.0 0.0 0
Financing Cash Flow 3.2 128.4 (1.0) 10.5 114.1 4.0 17.4 16.5 10.0 5.2 2.8 1.5 4.2 3.5 0.0 0.0 0.0
Cash Position
Net Change in Cash (52.0) 102.5 (51.5) (35.0) 101.8 (11.7) 2.7 7.5 2.5 0.4 0.1 (0.6) 0.6 (0.1) 0.0 (0.0) 0.0
Cash at Beginning 119.2 16.6 68.1 103.1 1.4 13.1 10.4 2.9 0.4 0.1 0 0.6 0.1 0.1 0.0 0.0 0.0
Cash at End 67.1 119.2 16.6 68.1 103.1 1.4 13.1 10.4 2.9 0.4 0.1 0 0.6 0.1 0.0 0.0 0.0
Free Cash Flow (42.3) (25.9) (49.9) (45.5) (12.3) (15.8) (14.7) (9.1) (7.5) (4.8) (2.8) (2.1) (3.6) (3.6) (0.0) (0.0) (0.0)
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
Income Statement
Revenue 0.5 1.1 (0.2) 1.1 1.1 0 0 0 1.2 0 0 0 0.2 1.3 0 0 0 0
Gross Profit 0.5 1.1 (0.2) 1.1 1.1 (0.1) 0 0 1.2 0 0 0 0.2 1.3 0 0 0 0
Operating Income (56.0) (33.0) (59.3) (47.8) (17.9) (20.0) (24.6) (14.2) (10.2) (17.9) (6.8) (5.0) (6.8) (9.0) (0.0) (0.0) (0.0) (0.0)
Net Income (51.4) (29.4) (59.2) (47.8) (17.9) (20.8) (24.6) (14.3) (10.3) (47.2) (13.9) (3.0) (12.9) (12.2) (0.0) (0.0) (0.0) (0.0)
EPS (Diluted) -1.67 -1.52 -8.51 -7.38 -14.74 -14.21 -25.83 -30.98 -40.85 -801.27 -315.87 -81.00 -426.98 -497.11 -0.46 -1.13 -0.95 -0.28
Balance Sheet
Cash & Equivalents 67.1 119.2 16.6 68.1 103.1 1.4 13.1 10.4 2.9 0.4 0.1 (0.0) 0.6 0.1 0.0 0.0 0.0 0
Total Assets 84.3 123.7 21.1 74.6 108.3 5.8 14.0 11.3 3.7 1.0 0.3 0.3 0.9 0.3 0.0 0.0 0.0 0
Total Debt 1.5 2.1 2.7 3.0 3.7 4.1 0.1 0.1 0.1 0.1 14.3 6.9 5.3 3.5 0.0 0.0 0.0 0
Stockholders' Equity 70.4 114.3 12.1 64.7 92.0 (5.7) 7.1 6.9 0.6 (3.0) (20.5) (12.8) (12.6) (5.7) (0.0) (0.0) 0.0 0
Cash Flow
Operating Cash Flow (42.1) (25.8) (49.7) (45.3) (12.1) (15.8) (14.5) (9.1) (7.3) (4.8) (2.8) (2.1) (3.5) (3.6) (0.0) (0.0) (0.0)
Capital Expenditure (0.2) (0.1) (0.2) (0.2) (0.3) 0 (0.2) (0.0) (0.2) (0.0) 0 (0.0) (0.1) (0.0) 0 0 (0.0)
Free Cash Flow (42.3) (25.9) (49.9) (45.5) (12.3) (15.8) (14.7) (9.1) (7.5) (4.8) (2.8) (2.1) (3.6) (3.6) (0.0) (0.0) (0.0)